Description
The Resistance of Cervical Cancer to Chemotherapy and its Reversal provides a holistic understanding of cervical cancer development, immune-evading mechanisms of HPV, immunotherapies available, methods to study cervical cancer and the development of newer drugs. Content shows the involvement of signaling pathways during chemoresistance in cervical cancer, the involvement of genes in drug resistance, and introduces long noncoding RNAs as novel biomarkers.In 10 chapters, this book first provides an introduction and history of cervical cancer; next, it discusses the influence of viruses on cervical cancer and finally, it describes therapies to overcome chemotherapy resistance in cervical cancer. This is the perfect reference to provide the fundamental base of knowledge needed for oncologists, pharmacologists, translational investigators, immunotherapists, scientists, and clinicians interested in building a comprehensive understanding of the field.- Focuses on the aspects of cervical cancer resistance towards therapies such as chemoresistance and radioresistance- Discusses the sensitizing agents that are being developed for the improvement of current therapies and better management of cervical cancer- Identifies the molecular mechanism of HPV integration and cervical cancer development
Table of Contents
1. Wnt signalling and cervical cancer2. Pharmacologial targets of cervical cancer3. PD-1, HPV and cervical cancer4. Radiotherapy and cervical cancer5. HPV and cervical cancer6. EGFR and cervical cancer7. Protein engineering for cervical cancer8. Anti-virals and cervical cancer9. Advances in cytological screening for cervical cancer10. microRNA and cervical cancer11. Computer aided drug designing for cervical cancer12. Nanoparticles for the treatment of cervical cancer
